EMS-CHEMIE HOLDING AG

BATS-CHIXE:EMSNZ Stock Report

Market Cap: CHF 14.7b

EMS-CHEMIE HOLDING Valuation

Is EMSNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EMSNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EMSNZ (CHF630.5) is trading above our estimate of fair value (CHF599)

Significantly Below Fair Value: EMSNZ is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMSNZ?

Key metric: As EMSNZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EMSNZ. This is calculated by dividing EMSNZ's market cap by their current earnings.
What is EMSNZ's PE Ratio?
PE Ratio31.8x
EarningsCHF 461.53m
Market CapCHF 14.69b

Price to Earnings Ratio vs Peers

How does EMSNZ's PE Ratio compare to its peers?

The above table shows the PE ratio for EMSNZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.5x
CRDA Croda International
30.6x15.1%UK£5.0b
JMAT Johnson Matthey
23.9x28.5%UK£2.6b
VCT Victrex
25.1x37.8%UK£770.5m
TET Treatt
22.5x15.3%UK£254.1m
EMSNZ EMS-CHEMIE HOLDING
31.8x8.8%CHF 14.7b

Price-To-Earnings vs Peers: EMSNZ is expensive based on its Price-To-Earnings Ratio (31.8x) compared to the peer average (25.5x).

Price to Earnings Ratio vs Industry

How does EMSNZ's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: EMSNZ is expensive based on its Price-To-Earnings Ratio (31.8x) compared to the European Chemicals industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is EMSNZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMSNZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio31.8x
Fair PE Ratio17x

Price-To-Earnings vs Fair Ratio: EMSNZ is expensive based on its Price-To-Earnings Ratio (31.8x) compared to the estimated Fair Price-To-Earnings Ratio (17x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EMSNZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 630.50
CHF 721.43
+14.4%
8.7%CHF 800.00CHF 650.00n/a7
Nov ’25CHF 675.50
CHF 735.71
+8.9%
11.7%CHF 900.00CHF 650.00n/a7
Oct ’25CHF 706.50
CHF 730.63
+3.4%
11.4%CHF 900.00CHF 633.00n/a8
Sep ’25CHF 709.50
CHF 730.63
+3.0%
11.4%CHF 900.00CHF 633.00n/a8
Aug ’25CHF 734.50
CHF 730.63
-0.5%
11.4%CHF 900.00CHF 633.00n/a8
Jul ’25CHF 737.25
CHF 675.00
-8.4%
10.5%CHF 800.00CHF 580.00n/a7
Jun ’25CHF 740.50
CHF 667.14
-9.9%
9.6%CHF 800.00CHF 580.00n/a7
May ’25CHF 737.00
CHF 664.29
-9.9%
9.8%CHF 800.00CHF 580.00n/a7
Apr ’25CHF 692.00
CHF 664.29
-4.0%
9.8%CHF 800.00CHF 580.00n/a7
Mar ’25CHF 623.00
CHF 655.71
+5.3%
12.2%CHF 800.00CHF 547.00n/a7
Feb ’25CHF 656.50
CHF 657.14
+0.1%
12.5%CHF 800.00CHF 547.00n/a7
Jan ’25CHF 679.50
CHF 657.14
-3.3%
12.5%CHF 800.00CHF 547.00n/a7
Dec ’24CHF 619.50
CHF 657.14
+6.1%
12.5%CHF 800.00CHF 547.00n/a7
Nov ’24CHF 623.00
CHF 704.57
+13.1%
11.4%CHF 850.00CHF 613.00CHF 675.507
Oct ’24CHF 621.00
CHF 704.57
+13.5%
11.4%CHF 850.00CHF 613.00CHF 706.507
Sep ’24CHF 665.50
CHF 700.29
+5.2%
11.6%CHF 850.00CHF 613.00CHF 709.507
Aug ’24CHF 726.00
CHF 700.71
-3.5%
11.5%CHF 850.00CHF 613.00CHF 734.507
Jul ’24CHF 675.00
CHF 712.86
+5.6%
14.3%CHF 900.00CHF 560.00CHF 737.257
Jun ’24CHF 703.00
CHF 716.43
+1.9%
14.5%CHF 900.00CHF 575.00CHF 740.507
May ’24CHF 729.50
CHF 720.71
-1.2%
14.5%CHF 900.00CHF 575.00CHF 737.007
Apr ’24CHF 756.00
CHF 722.57
-4.4%
14.4%CHF 900.00CHF 575.00CHF 692.007
Mar ’24CHF 717.50
CHF 702.50
-2.1%
15.1%CHF 900.00CHF 575.00CHF 623.006
Feb ’24CHF 682.00
CHF 684.17
+0.3%
16.6%CHF 900.00CHF 575.00CHF 656.506
Jan ’24CHF 626.50
CHF 684.17
+9.2%
16.6%CHF 900.00CHF 575.00CHF 679.506
Dec ’23CHF 671.50
CHF 700.83
+4.4%
17.8%CHF 900.00CHF 575.00CHF 619.506
Nov ’23CHF 617.00
CHF 756.57
+22.6%
19.4%CHF 1,001.00CHF 575.00CHF 623.007

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Altri SGPS

€1.0b

Produces and sells cellulosic fibers and energy in Portugal and internationally.

0DJV

€5.05

7D

-2.6%

1Y

5.5%

Navigator Company

€2.5b

Manufactures and markets pulp and paper products worldwide.

0KLO

€3.51

7D

-4.6%

1Y

-7.0%

Elkem

NOK 11.6b

Engages in the provision of advanced material solutions worldwide.

0SFN

NOK 18.36

7D

1.7%

1Y

1.3%